about
Aurora kinases as targets in drug-resistant neuroblastoma cellsEnergetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interactionp53 Family and Cellular Stress Responses in Cancer.Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type GlioblastomasAllele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.The role of DNA damage responses in p53 biology.Exploring Protein-Protein Interactions as Drug Targets for Anti-cancer Therapy with In Silico Workflows.A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53.
P2860
Q28543446-C55259BE-75E7-4243-864B-7DB8FE580775Q28550874-4037DFF0-2B13-499C-AFE2-CD986401FE74Q34377287-2E33B2D3-506B-444D-8503-7B00682FC0DCQ36828178-84B7EA46-C1D6-4612-A2E7-2856CEE9430FQ36905671-EB6C01C0-4434-4BC7-A0D3-0E0CF4582320Q38331206-04A9AE64-04F3-4D08-BCDC-D21EC48CA116Q38624559-D5049048-6A09-4ED1-924B-2B7E8D055AD8Q38774791-4F19CD43-3BBE-4866-B16B-93DD37BD2FEE
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Resistance acquisition to MDM2 inhibitors.
@en
type
label
Resistance acquisition to MDM2 inhibitors.
@en
prefLabel
Resistance acquisition to MDM2 inhibitors.
@en
P2093
P2860
P356
P1476
Resistance acquisition to MDM2 inhibitors
@en
P2093
Daniel Speidel
Ian Hardcastle
Jindrich Cinatl
P2860
P304
P356
10.1042/BST20140035
P577
2014-08-01T00:00:00Z